Movano Health Announces Blood Pressure Partnership Forum To Debut Its Cuffless Monitoring Device

Movano Health, a health technology company is debuting its cuffless blood pressure monitoring device at investor events after a recent clinical trial showed that the device accuracy was within the standards recognized by the U.S. Food & Drug Administration (FDA) for blood pressure monitoring devices. The prototype achieved an overall mean absolute difference (MAD) of 5.9 mmHg, which is below the FDA’s 7 mmHg MAD required per a standard for wearable, cuffless blood pressure measuring devices (IEEE1708a-2019). Movano Health is also evaluating artificial intelligence (AI)-based individual calibration methods to further enhance the future performance of . . .